Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 341 - 360 of 447 trials
Title Investigatorsort icon Disease(s)
A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243]
Dunkel, Ira
  • Germ Cell Tumors
  • Pediatric Brain Tumors
    • CNS Cancer
A Phase I Study of AZD6244 in Pediatric Patients with Recurrent or Refractory Low-Grade Glioma (PBTC-029)
[Protocol 12-151]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
[Protocol 13-043]
Dunkel, Ira
  • Melanoma
Treatment of Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation
[Protocol 09-070]
Dunkel, Ira
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072]
Dunkel, Ira
  • Retinoblastoma
The Sexual Health of Rectal Cancer Patients: A Pilot Study
[Protocol 08-073]
DuHamel, Katherine
  • Colorectal Cancer
    • Rectal Cancer
  • Survivorship
A Phase III Study of Elacytarabine versus Investigator's Choice in Patients with Late-Stage Acute Myeloid Leukemia
[Protocol 10-113]
Douer, Dan
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase II Study of Blinatumomab in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-069]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
A Phase I Study of Actinium-225-Labeled HuM195 Antibody in Patients with Advanced Myeloid Malignancies
[Protocol 02-017]
Douer, Dan
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
A Phase I Study of BMS-906024 in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
[Protocol 11-181]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants
[Protocol 06-024]
Disa, Joseph
  • Breast Cancer
  • Survivorship
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I/II Study of Lenalidomide in Patients with AIDS-Associated Kaposi's Sarcoma
[Protocol 10-116]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase I Study of AMP-224 with a Cyclophosphamide-Containing Regimen in Patients with Advanced Melanoma
[Protocol 12-127]
Dickson, Mark
  • Melanoma
A Pilot Trial of Bortezomib in Patients with Relapsed/Refractory AIDS-associated Kaposi Sarcoma
[Protocol 10-117]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063]
Dickler, Maura
  • Breast Cancer
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura
  • Breast Cancer